Other News To Note
• Active Biotech AB, of Lund, Sweden, and Teva Pharmaceutical Industries Ltd., of Jerusalem, reported that following a meeting with the FDA, Teva determined it would be premature to file a new drug application for multiple sclerosis drug laquinimod, and that the FDA has offered to work with Teva to determine the best design for conducting an additional trial.
• Aslan Pharmaceuticals Pte Ltd., of Singapore, is partnering with Bristol-Myers Squibb Co., of New York, to accelerate the development of BMS
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST